NATURE’S SUNSHINE PRODUCTS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of 1.50% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-03-10
- NATURE’S SUNSHINE PRODUCTS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2025 was 1.50%, a 54.55% decline from fiscal 2024.
- NATURE’S SUNSHINE PRODUCTS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2024 was 3.30%.
- NATURE’S SUNSHINE PRODUCTS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2023 was -0.10%.
- NATURE’S SUNSHINE PRODUCTS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2022 was -2.40%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 1.50% 10-K · filed 2026-03-10 | |
| 2024-12-31 | 3.30% 10-K · filed 2026-03-10 | -0.20% 10-K · filed 2025-03-11 |
| 2023-12-31 | -0.10% 10-K · filed 2025-03-11 | |
| 2022-12-31 | -2.40% 10-K · filed 2024-03-12 | |
| 2021-12-31 | -4.00% 10-K · filed 2023-03-16 | |
| 2020-12-31 | -0.40% 10-K · filed 2022-03-08 | |
| 2019-12-31 | 7.10% 10-K · filed 2021-03-10 | |
| 2018-12-31 | 12.70% 10-K · filed 2020-03-11 | |
| 2017-12-31 | 0.00% 10-K · filed 2019-03-08 | |
| 2016-12-31 | 0.00% 10-K · filed 2019-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |